Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -8.00 (-5.52%)
Bid:
137.00
Ask:
144.50
Spread: 7.50 (5.474%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

14 Oct 2009 07:00

RNS Number : 7141A
Xaar PLC
14 October 2009
Β 

ο»Ώ

FOR IMMEDIATE RELEASE

14Β OctoberΒ 2009

Xaar plc

INTERIM MANAGEMENTΒ STATEMENT

Xaar plc ("Xaar"Β or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1Β July 2009 toΒ 30 SeptemberΒ 2009.

TradingΒ and marginsΒ for the third quarter of the year wereΒ in line withΒ the Board'sΒ expectationsΒ and wereΒ broadly stableΒ at the levels seen inΒ the first and second quartersΒ of 2009.

Launches of printing machines based on Xaar's Platform 3 technology continue, with eight of our OEM (original equipment manufacturer) customers exhibiting Platform 3 based machines at the recent Label Expo trade show held inΒ Brussels. Sales of Platform 3 products are predominantly to customers based in Western Europe andΒ North AmericaΒ and, whilst continuing to show modest growth over previous quarters, are still subject to the lengthy transition period between product launch and volume salesΒ - a process which is exacerbated byΒ the global recession. Sales of Xaar's other product ranges are consistent with previous periods.

The consolidation of theΒ Group'sΒ manufacturing facilities into a single plant inΒ Huntingdon,Β EnglandΒ is progressing to schedule. The design and planning phase of the programmeΒ is now complete and the first productionΒ processesΒ have been relocatedΒ successfully. The overall time frame for the project remains at two years from March 2009;Β the costs and benefits of the project are in line with the original plan.

The Group'sΒ balance sheetΒ remainsΒ strong. Net cash at 30 September 2009 was Β£9.6m (31 December 2008: Β£11.0m, 30 June 2009: Β£10.3m) after the payment of Β£1.5m of dividendsΒ (2008 final: Β£0.9m, 2009 interim: Β£0.6m)Β in the yearΒ to date.

The Board remains satisfied with the continuing stability in trading seen in the period. The overall trading environment remains unchanged from the time ofΒ theΒ Half Yearly ReportΒ in August 2009.Β Β There is still aΒ lack ofΒ forwardΒ visibility of customer ordersΒ which, together withΒ theΒ ongoingΒ uncertaintyΒ in theΒ globalΒ business environment,Β contribute to a level of caution when lookingΒ ahead.Β 

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance DirectorΒ 

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Steve Liebmann or Andy Harris

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBUBDGSUBGGCX
Date   Source Headline
2nd Jun 202612:58 pmRNSTotal Voting Rights
28th May 20269:18 amRNSResult of AGM
6th May 20267:00 amRNSDirector/PDMR Shareholding
5th May 202611:36 amRNSHolding(s) in Company
30th Apr 20264:44 pmRNSHolding(s) in Company
16th Apr 20269:00 amRNSPublication of Annual Report and Notice of AGM
1st Apr 20263:43 pmRNSHolding(s) in Company
24th Mar 20267:05 amRNSFinal Results
23rd Mar 20263:33 pmRNS-RInvestor Presentation via Investor Meet Company
2nd Mar 20262:44 pmRNSTotal Voting Rights
14th Jan 20267:00 amRNSTrading Statement
5th Jan 202612:28 pmRNSTotal Voting Rights
5th Dec 20251:15 pmRNSHolding(s) in Company
1st Dec 202512:15 pmRNSTotal Voting Rights
24th Nov 202511:00 amRNSDirector/PDMR Shareholding
3rd Nov 20252:00 pmRNSTotal Voting Rights
21st Oct 20254:15 pmRNSDirector/PDMR Shareholding
13th Oct 20253:20 pmRNSHolding(s) in Company
2nd Oct 202511:10 amRNSDirector/PDMR Shareholding
2nd Oct 20258:50 amRNSDirector/PDMR Shareholding
1st Oct 20255:00 pmRNSDirector/PDMR Shareholding
1st Oct 20253:30 pmRNSTotal Voting Rights
1st Oct 202512:04 pmRNSTRADING UPDATE and NOTICE OF RESULTS
1st Sep 20254:30 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNS2025 INTERIM RESULTS
5th Aug 20257:00 amRNSBoard changes
1st Aug 20253:45 pmRNSTotal Voting Rights
14th Jul 202510:00 amRNSNotice of Interim Results
7th Jul 20253:30 pmRNSBlock listing Interim Review
2nd Jul 20253:30 pmRNSTotal Voting Rights
30th Jun 20252:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202510:00 amRNSTotal Voting Rights
28th May 20253:30 pmRNSResult of AGM
21st May 20251:00 pmRNSHolding(s) in Company
7th May 20253:30 pmRNSNotification of Transactions of Directors & PDMRs
2nd May 202510:30 amRNSTotal Voting Rights
15th Apr 20251:15 pmRNS2024 Annual Report and Notice of AGM
11th Apr 202512:00 pmRNSHolding(s) in Company
1st Apr 20254:15 pmRNSHolding(s) in Company
1st Apr 20253:30 pmRNSTotal Voting Rights
31st Mar 20253:45 pmRNSNotification of Transactions of Directors & PDMRs
31st Mar 20251:10 pmRNSHolding(s) in Company
28th Mar 202511:30 amRNSHolding(s) in Company
27th Mar 202511:00 amRNSHolding(s) in Company
25th Mar 20255:00 pmRNSNotification of Transactions of Directors & PDMRs
25th Mar 20257:00 amRNSFinal Results
5th Mar 202511:30 amRNSTotal Voting Rights
19th Feb 202510:30 amRNSHolding(s) in Company
10th Feb 202511:00 amRNSHolding(s) in Company
5th Feb 20254:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.